Medical magnetic resonance imaging (MRI) produces high-resolution anatomical images of the human body, but has limited capacity to provide useful molecular information. The light-responsive, liposomal MRI contrast agent described herein could be used to provide an intrinsic theranostic aspect to MRI and enable tracking the distribution and cargo release of drug delivery systems upon light-triggered activation.

Originele taal-2English
Pagina's (van-tot)10784-10787
Aantal pagina's4
TijdschriftChemical communications (Cambridge, England)
Nummer van het tijdschrift72
StatusPublished - 16-sep-2019

Citeer dit